Treatment of Cervical Spinal Cord Injury With Imatinib - a Safety and Feasibility Study

NCT02363361 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Cervical Spinal Cord Injury

Interventions

DRUG: Imatinib

Sponsor

Professor Mikael Svensson, MD PhD